Oculus Progression (34)

Showing records 1 to 25

Display only abstracts from IGR 21-3 in classification Progression

Search within classification Progression

90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Lin FB; Da Chen S; Song YH; Wang W; Jin L; Liu BQ; Liu YH; Chen ML; Gao K; Friedman DS; Jonas JB; Aung T; Lv L; Liu YZ; Zhang XL;
Trials 2020; 21: 813 (IGR: 21-3)

53254 Visual field progression outcomes in glaucoma subtypes
De Moraes CG; Liebmann JM; Liebmann CA; Susanna R; Tello C; Ritch R
Acta Ophthalmologica 2013; 91: 288-293 (IGR: 15-2)

52403 Rates of visual field loss before and after trabeculectomy
Bertrand V; Fieuws S; Stalmans I; Zeyen T
Acta Ophthalmologica 2014; 92: 116-120 (IGR: 15-1)

46323 Influence of Visual Field Testing Frequency on Detection of Glaucoma Progression With Trend Analyses
Nouri-Mahdavi K; Zarei R; Caprioli J
Archives of Ophthalmology 2011; (IGR: 13-3)

46015 Effect of successful and partly successful filtering surgery on the velocity of glaucomatous visual field progression
Folgar FA; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
Journal of Glaucoma 2011; (IGR: 13-2)

27800 A Randomized Trial of Brimonidine Versus Timolol in Preserving Visual Function: Results From the Low-pressure Glaucoma Treatment Study
Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S
American Journal of Ophthalmology 2011; 151: 671-681 (IGR: 13-1)

26988 Methodologic Quality of Studies on Prognostic Factors for Primary Open-angle Glaucoma Progression Measured by Visual Field Deterioration.
Júlvez LP; Del Castillo Sánchez JB; Feijoo JG; Rubio-Terrés C
Journal of Glaucoma 2010; 19: 587-591 (IGR: 12-4)

26455 Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: Subgroup and subfield analyses of the nipradilol-timolol study
Araie M; Shirato S; Yamazaki Y; Kitazawa Y; Ohashi Y
Japanese Journal of Ophthalmology 2010; 54: 278-285 (IGR: 12-3)

26545 Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma
Pajic B; Pajic-Eggspuehler B; Hafliger IO
Current Medical Research and Opinion 2010; 26: 2213-2219 (IGR: 12-3)

25069 Glaucoma surgery decreases the rates of localized and global visual field progression
Folgar FA; De Moraes CG; Prata TS; Teng CC; Tello C; Ritch R; Liebmann JM
American Journal of Ophthalmology 2010; 149: 258-264 (IGR: 12-1)

25196 Long-term benefit of reduced intraocular pressure in primary open-angle glaucoma patients in Ethiopia
Alemu AM; Kristoffersen CJ; Kristoffersen MS; Stewart JA; Stewart WC
European Journal of Ophthalmology 2010; 20: 310-315 (IGR: 12-1)

24829 Optic disc and visual field changes after trabeculectomy
Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A; MoreFlow Study Group
Investigative Ophthalmology and Visual Science 2009; 50: 4693-4699 (IGR: 11-4)

24730 Visual field progression in moderate and severe primary open angle glaucoma patients after trabeculectomy
Wang W-J; Yuan Y-S
International Journal of Ophthalmology 2009; 9: 1502-1504 (IGR: 11-4)

22680 Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors
Musch DC; Gillespie BW; Lichter PR; Niziol LM; Janz NK; CIGTS Study Investigators
Ophthalmology 2009; 116: 200-207 (IGR: 11-1)

20954 Visual field changes after transient elevation of intraocular pressure in eyes with and without glaucoma
Chan KC; Poostchi A; Wong T; Insull EA; Sachdev N; Wells AP
Ophthalmology 2008; 115: 667-672 (IGR: 10-2)

21013 Comparison of HRT-3 glaucoma probability score and subjective stereophotograph assessment for prediction of progression in glaucoma
Alencar LM; Bowd C; Weinreb RN; Zangwill LM; Sample PA; Medeiros FA
Investigative Ophthalmology and Visual Science 2008; 49: 1898-1906 (IGR: 10-2)

20583 Update on the natural history of glaucoma
Hitchings R
Eye 2007; 21: S2-S5 (IGR: 10-1)

20734 Risk factors for primary open angle glaucoma progression: what we know and what we need to know
Rivera JL; Bell NP; Feldman RM
Current Opinions in Ophthalmology 2008; 19: 102-106 (IGR: 10-1)

20619 Long-term intraocular pressure fluctuation and visual field progression in glaucoma patients with low intraocular pressure after post-trabeculectomy phacoemulsification
Hong S; Kim CY; Seong GJ
Journal of Ocular Pharmacology and Therapeutics 2007; 23: 571-575 (IGR: 10-1)

20427 Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data
Broman AT; Quigley HA; West SK; Katz J; Munoz B; Bandeen-Roche K; Tielsch JM; Friedman DS; Crowston J; Taylor HR
Investigative Ophthalmology and Visual Science 2008; 49: 66-76 (IGR: 10-1)

20340 A visual field index for calculation of glaucoma rate of progression
Bengtsson B; Heijl A
American Journal of Ophthalmology 2008; 145: 343-353 (IGR: 10-1)

20036 Predictors of long-term progression in the Early Manifest Glaucoma Trial
Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z; EMGT Group
Ophthalmology 2007; 114: 1965-1972 (IGR: 9-4)

19930 Ten-year outcomes in newly diagnosed glaucoma patients: mortality and visual function
Sharma T; Salmon JF
British Journal of Ophthalmology 2007; 91: 1282-1284 (IGR: 9-4)

19463 Visual field damage and progression in glaucomatous myopic eyes
Perdicchi A; Iester M; Scuderi G; Amodeo S; Medori EM; Recupero SM
European Journal of Ophthalmology 2007; 17: 534-537 (IGR: 9-3)

19535 Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy
Law SK; Nguyen AM; Coleman AL; Caprioli J
Archives of Ophthalmology 2007; 125: 1044-1050 (IGR: 9-3)

Issue 21-3

Change Issue